Last updated: 21 June 2024 at 6:15pm EST

Franklin Berger Net Worth




The estimated Net Worth of Franklin M Berger is at least 2.16 百万$ dollars as of 16 June 2024. Mr. Berger owns over 33,150 units of Kezar Life Sciences Inc stock worth over 470,672$ and over the last 20 years he sold KZR stock worth over 1,588,083$. In addition, he makes 97,434$ as Independent Director at Kezar Life Sciences Inc.

Mr. Berger KZR stock SEC Form 4 insiders trading

Franklin has made over 36 trades of the Kezar Life Sciences Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 33,150 units of KZR stock worth 19,227$ on 16 June 2024.

The largest trade he's ever made was selling 272,840 units of Kezar Life Sciences Inc stock on 14 December 2022 worth over 728,483$. On average, Franklin trades about 15,100 units every 47 days since 2004. As of 16 June 2024 he still owns at least 811,503 units of Kezar Life Sciences Inc stock.

You can see the complete history of Mr. Berger stock trades at the bottom of the page.





Franklin Berger biography

Franklin M. Berger, CFA., is Independent Director of the Company. Mr. Berger worked at Sectoral Asset Management as a founder of the small-cap focused NEMO Fund from January 2007 through June 2008. Prior to that, he served at J.P. Morgan Securities, most recently as Managing Director, Equity Research and Senior Biotechnology Analyst and served in similar capacities at Salomon Smith Barney and Josephthal & Co. Mr. Berger has served as a member of the board of directors of Five Prime Therapeutics, Inc. since October 2014, Tocagen Inc. since October 2014, Bellus Health, Inc. since May 2010, ESSA Pharma, Inc. since March 2015, and Proteostasis Therapeutics, Inc. since February 2016. Mr. Berger previously served as a member of the board of directors BioTime, Inc., Seattle Genetics, Inc. and Immune Design Corp., each publicly held biotechnology companies.

What is the salary of Franklin Berger?

As the Independent Director of Kezar Life Sciences Inc, the total compensation of Franklin Berger at Kezar Life Sciences Inc is 97,434$. There are 9 executives at Kezar Life Sciences Inc getting paid more, with John Fowler having the highest compensation of 3,532,020$.



How old is Franklin Berger?

Franklin Berger is 70, he's been the Independent Director of Kezar Life Sciences Inc since 2016. There are no older and 14 younger executives at Kezar Life Sciences Inc.

What's Franklin Berger's mailing address?

Franklin's mailing address filed with the SEC is 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110.

Insiders trading at Kezar Life Sciences Inc

Over the last 6 years, insiders at Kezar Life Sciences Inc have traded over 3,836,099$ worth of Kezar Life Sciences Inc stock and bought 6,372,267 units worth 30,891,130$ . The most active insiders traders include Venture Investments Ltd Mor...Asset Management, Lp Chen B...Franklin M Berger. On average, Kezar Life Sciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of 91,954$. The most recent stock trade was executed by Mark C. Schiller on 2 July 2024, trading 6,688 units of KZR stock currently worth 3,879$.



What does Kezar Life Sciences Inc do?

kezar life sciences, inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the united states. the company's lead product candidate is kzr-616, a selective immunoproteasome inhibitor that is in phase 2 clinical trials across five autoimmune indications, including lupus nephritis, autoimmune hemolytic anemia, immune thrombocytopenia, dermatomyositis, and polymyositis; and phase 1b/2 clinical trials in systemic lupus erythematosus and lupus nephritis. its preclinical products include kzr-616, a selective immunoproteasome inhibitor for the treatment of various autoimmune disease indications; and kzr-tbd for the treatment of oncology and autoimmunity. the company was founded in 2015 and is headquartered in south san francisco, california.



What does Kezar Life Sciences Inc's logo look like?

Kezar Life Sciences Inc logo

Complete history of Mr. Berger stock trades at Essa Pharma Inc、Five Prime Therapeutics Inc、Proteostasis Therapeutics Inc、Seagen Inc、Tocagen、Kezar Life Sciences Inc、Atreca Inc、Atea Pharmaceuticals

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
16 Jun 2024 Franklin M Berger
オプション行使 33,150 3.61$ 119,672$
16 Jun 2024
811,503
11 Nov 2022 Franklin M Berger
販売 41,666 5.15$ 214,580$
11 Nov 2022
778,353
3 Nov 2020 Franklin M Berger
購入する 41,666 24.00$ 999,984$
3 Nov 2020
820,019
21 Nov 2023 Franklin M Berger
購入する 23,259 5.73$ 133,274$
21 Nov 2023
784,404
2 Nov 2023 Franklin M Berger
購入する 76,471 5.49$ 419,826$
2 Nov 2023
760,875
14 Dec 2022 Franklin M Berger
販売 272,840 2.67$ 728,483$
14 Dec 2022
684,404
22 Feb 2021 Franklin M Berger
購入する 57,000 27.00$ 1,539,000$
22 Feb 2021
957,244
3 Dec 2020 Franklin M Berger
オプション行使 42,207 3.64$ 153,633$
3 Dec 2020
900,244
18 Mar 2022 Franklin M Berger
購入する 80,000 16.25$ 1,300,000$
18 Mar 2022
890,691
21 Sep 2021 Franklin M Berger
オプション行使 26,688 6.38$ 170,269$
21 Sep 2021
810,691
11 Jun 2020 Franklin M Berger
購入する 100,000 5.50$ 550,000$
11 Jun 2020
784,003
4 Feb 2020 Franklin M Berger
購入する 120,846 2.60$ 314,200$
4 Feb 2020
684,003
25 Jun 2018 Franklin M Berger
購入する 50,000 15.00$ 750,000$
25 Jun 2018
563,157
2 Dec 2019 Franklin M Berger
ディレクター
販売 79,980 3.97$ 317,521$
2 Dec 2019
5,000
22 Apr 2016 Franklin M Berger
ディレクター
購入する 5,000 49.47$ 247,350$
22 Apr 2016
84,980
19 Apr 2016 Franklin M Berger
ディレクター
購入する 6,090 47.06$ 286,595$
19 Apr 2016
79,980
22 Sep 2015 Franklin M Berger
ディレクター
オプション行使 12,500 12.70$ 158,750$
22 Sep 2015
73,890
2 Sep 2015 Franklin M Berger
ディレクター
オプション行使 8,130 7.88$ 64,064$
2 Sep 2015
61,390
1 Jul 2015 Franklin M Berger
ディレクター
オプション行使 6,504 6.05$ 39,349$
1 Jul 2015
53,260
17 Jun 2015 Franklin M Berger
ディレクター
オプション行使 9,756 6.89$ 67,219$
17 Jun 2015
46,756
28 Jan 2015 Franklin M Berger
ディレクター
購入する 25,000 27.03$ 675,750$
28 Jan 2015
37,000
14 Jan 2015 Franklin M Berger
ディレクター
購入する 10,049 26.17$ 262,982$
14 Jan 2015
12,000
28 Nov 2014 Franklin M Berger
ディレクター
購入する 1,951 21.04$ 41,049$
28 Nov 2014
1,951
26 Oct 2018 Franklin M Berger
ディレクター
購入する 40,000 6.75$ 270,000$
26 Oct 2018
40,000
18 Dec 2017 Franklin M Berger
ディレクター
購入する 60,000 5.00$ 300,000$
18 Dec 2017
266,162
15 Dec 2016 Franklin M Berger
ディレクター
購入する 40,000 11.17$ 446,800$
15 Dec 2016
206,162
14 Sep 2016 Franklin M Berger
ディレクター
購入する 69,230 13.00$ 899,990$
14 Sep 2016
166,162
17 Feb 2016 Franklin M Berger
ディレクター
購入する 25,000 8.00$ 200,000$
17 Feb 2016
96,932
21 Feb 2014 Franklin M Berger
ディレクター
オプション行使 7,500 12.76$ 95,700$
21 Feb 2014
204,720
28 Aug 2013 Franklin M Berger
ディレクター
オプション行使 10,000 12.76$ 127,600$
28 Aug 2013
197,220
23 Aug 2012 Franklin M Berger
ディレクター
オプション行使 20,000 10.14$ 202,800$
23 Aug 2012
183,720
22 Jun 2011 Franklin M Berger
ディレクター
購入する 7,000 20.04$ 140,280$
22 Jun 2011
163,720


Kezar Life Sciences Inc executives and stock owners

Kezar Life Sciences Inc executives and other stock owners filed with the SEC include: